A rating of 81 puts Codexis, Inc. (CDXS) near the top of the Biotechnology industry according to InvestorsObserver. Codexis, Inc.'s score of 81 means it scores higher than 81% of stocks in the industry. Codexis, Inc. also received an overall rating of 64, putting it above 64% of all stocks. Biotechnology is ranked 33 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Codexis, Inc. Stock Today?
Codexis, Inc. (CDXS) stock is trading at $26.13 as of 10:16 AM on Tuesday, Feb 2, a rise of $2.22, or 9.28% from the previous closing price of $23.91. The stock has traded between $24.93 and $26.71 so far today. Volume today is light. So far 253,983 shares have traded compared to average volume of 799,470 shares.
Click Here to get the full Stock Score Report on Codexis, Inc. (CDXS) Stock.
